Invizyne Technologies Inc

Research Invizyne Technologies Inc (EXOZ) on Bullrun: market cap USD 69.89M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is USD 69.89M.

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2025USD 0-USD 9.16M-USD 6.67Mn/a-1.09USD 3.04MUSD 1.24MUSD 3.40M
FY2024USD 0-USD 5.86M-USD 8.90Mn/a-0.89USD 9.72MUSD 1.39MUSD 10.42M
FY2023USD 70.07K-USD 2.04M-USD 1.47Mn/a-0.33USD 66.53KUSD 1.61M-USD 384.32K

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-08-25USD 69.89Mn/an/an/a
20252025-12-31USD 91.63Mn/an/an/a
20242024-12-31USD 138.07Mn/an/an/a

About Invizyne Technologies Inc

eXoZymes, Inc. operates as a development stage biotechnology company. It focuses on the development of enzyme modules and cell-free exozyme biosolutions for synthetic biology manufacturing. The company was formerly known as Invizyne Technologies, Inc. and changed its name to eXoZymes, Inc. in February 2025. eXoZymes, Inc. was incorporated in 2014 and is headquartered in Monrovia, California.

Related stock research

Other Healthcare stocks

Frequently asked questions

What is Invizyne Technologies Inc's market cap?

Invizyne Technologies Inc's market capitalization is USD 69.89M.

What does Invizyne Technologies Inc do?

eXoZymes, Inc. operates as a development stage biotechnology company. It focuses on the development of enzyme modules and cell-free exozyme biosolutions for synthetic biology manufacturing. The company was formerly known as Invizyne Technologies, Inc. and changed its name to eXoZymes, Inc. in February 2025. eXoZymes, Inc. was incorporated in 2014 and is headquartered in Monrovia, California.